10,160
Total Claims
$5.1M
Drug Cost
1,858
Beneficiaries
$2,721
Cost/Patient
Peer Comparison vs. 13,195 Dermatology providers
+125%
Cost per patient vs peers
$2,721 vs $1,209 avg
+38%
Brand preference vs peers
10.3% vs 7.5% avg
Brand vs Generic
90% generic
Brand: 1,051 claims · $4.5M
Generic: 9,109 claims · $523K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Risankizumab-Rzaa | 54 | $1.2M |
| Dupilumab | 162 | $628K |
| Secukinumab | 71 | $615K |
| Guselkumab | 38 | $536K |
| Adalimumab | 47 | $516K |
| Dupilumab | 37 | $164K |
| Ixekizumab | 16 | $145K |
| Apremilast | 16 | $75K |
| Ruxolitinib Phosphate | 28 | $66K |
| Triamcinolone Acetonide | 1,532 | $65K |
| Tacrolimus | 201 | $57K |
| Calcipotriene | 115 | $44K |
| Clindamycin Phosphate | 451 | $36K |
| Ketoconazole | 1,143 | $32K |
| Clobetasol Propionate | 338 | $32K |
Prescribing Profile
53
Unique Drugs
Patient Profile
66
Avg Age
55%
Female
1.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About